Impaired respiratory function in women with PCOS compared to matched controls from a population-based study.
Increased prevalence of asthma is reported from epidemiological studies in women with PCOS. To investigate respiratory function in women with PCOS compared to controls in a clinical setting. 8-year clinical follow-up including self-reported asthma diagnoses and spirometry of women with PCOS randomized to metformin or placebo during pregnancy in the original studies (the Pilot and the PregMet-study), compared to matched controls from a population-based cohort study (The HUNT Study). Secondary and tertiary care centers. 145 women with PCOS (54% of original cohort) were matched 1:3 to controls, on gender, age and smoking-status. Self-reported doctor diagnosed asthma (DDA), FEV1 % predicted, FVC % predicted. Women with PCOS reported more DDA compared to controls (19% vs 9%, p<0.01). Spirometry indicated a combined obstructive (FEV1 % predicted 93.7 vs 102.0, p<0.01) and restrictive (FVC % predicted 94.5 vs 103.7, p<0.01) respiratory impairment in PCOS compared to controls. Metformin in pregnancy did not affect respiratory function at follow-up. Women with PCOS reported higher prevalence of DDA compared to age and smoking-status matched controls. In addition, respiratory function was decreased, with both obstructive and restrictive components. Further insight to the underlying pathogenesis of these observations is needed.